Distribution of T<sub>naïve</sub>, T<sub>CM</sub>, T<sub>EM</sub> subpopulations of CD4<sup>+</sup>T lymphocytes and IL-17<sup>+</sup>/T<sub>EM</sub> subpopulations of CD4<sup>+</sup> T lymphocytes.
- Byung Ha Chung (314449)
- Kyoung Woon Kim (314451)
- Bo-Mi Kim (314453)
- Kyoung Chan Doh (394391)
- Mi-La Cho (46882)
- Chul Woo Yang (277266)
DOIAbstract
<p><b>(A)</b> PBMCs were stained with anti-CD4 PE-cy7, anti-CD45RA–FITC, anti-CCR7 APC and anti-IL-17 PE. CD4+ T cells were gated for further analysis. <b>(B)</b> The proportion (%) of T<sub>naïve</sub>/CD4<sup>+</sup> T (CD45RA<sup><i>+</i></sup>CCR7<sup>+</sup>/CD4<sup>+</sup> Tcells) <b>(C)</b> T<sub>CM</sub>/CD4<sup>+</sup> T (CD45RA<sup>–</sup>CCR7<sup>+</sup>/CD4<sup>+</sup>Tcells) <b>(D)</b> T<sub>EM</sub>/CD4<sup>+</sup> T (CD45RA<sup>–</sup>CCR7<sup>–</sup>/CD4<sup>+</sup> Tcells) <b>(E)</b> After surface staining with CD45 and CCR7 mAbs, analysis of IL-17 in CD4<sup>+</sup> T cell subsets by intracellular flow cytometry was done. <b>(F)</b> The proportion (%) of IL-17<sup>+</sup>/T<sub>EM.</sub> in each patient group. * <i>P</i><0...
Add to ORKG